AZD7798 Placebo: 0.9% saline solution for injection, commercially available., AZD7798
D9690C00006
Phase 2 small_molecule active
Quick answer
AZD7798 Placebo: 0.9% saline solution for injection, commercially available., AZD7798 for Crohn’s Disease and an Ileostomy is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Crohn’s Disease and an Ileostomy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active